GSSG functions as a hydrogen acceptor in the enzymatic determination of NADP+ and NADPH and can be a proximal donor in S-glutathionylation post translational modifications
For those without insurance benefits for semaglutide, various savings programs may help reduce expenses
This is going to be a trillion-dollar drug. @hubermanlab says retatrutide is the peptide thats about to change everything. Currently in a Phase III clinical trial in humans, retatrutide caused up to one-third body weight loss in just six months, with some degree of muscle sparing
GLP-1 receptors are present on cardiomyocytes, endocardium, microvascular endothelium, and coronary smooth muscle cells [10.0]
Both drugs caused weight loss (with Retatrutide double the weight loss), and regained weight after withdrawal of the GLP-1R agonist
This suggests that the hair loss is not strictly dose-dependent in a linear way but rather connected to the metabolic changes that all therapeutic doses trigger, including significant weight loss with tirzepatide